Tekcapital Says Belluscura Launches Passport In US

LONDON (Alliance News) - Tekcapital PLC on Friday said investee company ...

Alliance News 3 March, 2017 | 7:03PM
Email Form

LONDON (Alliance News) - Tekcapital PLC on Friday said investee company Belluscura, in which it has a 65% stake, has launched its Passport product in the US.

Passport is a medical device used in keyhole surgery, as the access point for an endoscope camera.

"The launch of this Passport trocar provides Belluscura with a presence in the surgical device field. Passport is the first of a family of trocars and cannulae that Belluscura will seek to launch over the coming years. Together, these will form a range of products to support surgeons in an array of specialties," said Chief Executive Officer Bob Rauker in a statement.

Shares in Tekcapital were up 1.2% at 44.00 pence Friday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2017 Alliance News Limited. All Rights Reserved.

Email Form
Securities Mentioned in Article
Security Name Price Change (%) Morningstar Rating
Tekcapital PLC 31.00 GBX 0.00 -
About Author Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.